Phase 1 GvHD Clinical Trials

4 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–4 of 4 trials

Recruiting

Phase 1Phase 2

Prebiotic Galacto-oligosaccharide and Acute GVHD

Acute GVHD

University of Kansas Medical Center128 enrolled2 locationsNCT04373057

Recruiting

Phase 1

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Hematologic MalignancyGvHDGVHD,Acute+8 more

Tr1X, Inc.36 enrolled5 locationsNCT06462365

Completed

Phase 1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NJA-730 in Healthy Volunteers

Acute graft-versus-host disease (aGvHD)

NapaJen Pharma Inc.104 enrolled1 locationACTRN12618001428257

Not Yet Recruiting

Phase 1

Pharmacokinetics and Safety of Solid Oral Posaconazole(SCH 56592) in Subjects at High Risk for Invasive Fungal Infections

High Risk for Invasive Fungal Infection due to: - Hematopoietic stem cell transplant (HSCT) recipients undergoing treatment for graft-versus-host disease (GVHD)High Risk for Invasive Fungal Infection due to: - Expected neutropenia (low white blood cell count) due to chemotherapy for Acute Myelogenous Leukaemia (AML) or Myelodysplastic Syndrome (MDS)

Schering-Plough Pty limited160 enrolled1 locationACTRN12611000364976